Lung Cancer Trial, Recruiting NCT07227623 Sponsor: Massachusetts General Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07227623
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with early-to-mid stage non-small cell lung cancer (stages I, II, or III)
  • You have started, or are about to start, treatment aimed at curing your cancer — this includes chemotherapy with or without immunotherapy, either before or after surgery, or combined with radiation therapy — and this must be within six weeks of beginning that treatment
  • You are able to carry out at least some daily activities and are up and about for more than half of your waking hours (confirm with trial site)
  • You are able to use a digital health tool that provides information in written and spoken English
  • You are able to fill out questionnaires in either English or Spanish
  • You receive your main cancer care at one of the hospitals or clinics taking part in this trial

Who may not be able to join:

  • You have a serious, uncontrolled mental health condition, or another significant health condition such as dementia or memory/thinking problems, that your cancer doctor feels would prevent you from taking part in the study activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 February 2026
Est. completion
28 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient-reported Physical Function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov